This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fedorko, D. P.
Right arrow Articles by Williams, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fedorko, D. P.
Right arrow Articles by Williams, E. C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 05 1997, 1258-1259, Vol 35, No. 5
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Use of cycloserine-cefoxitin-fructose agar and L-proline-aminopeptidase (PRO Discs) in the rapid identification of Clostridium difficile

DP Fedorko and EC Williams
Clinical Pathology Department, Warren G. Magnuson, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892, USA. dfedorko@nih.gov

The PRO Disc (Carr-Scarborough Microbiologicals, Inc., Decatur, Ga.) can be used to screen for L-proline-aminopeptidase produced by Clostridium difficile grown on cycloserine-cefoxitin-fructose agar (CCFA). Fifty stored isolates of C. difficile (48 toxin-positive and 2 toxin-negative isolates) and 47 fresh C. difficile isolates (39 toxin- positive and 8 toxin-negative isolates) were all PRO Disc positive. Other Clostridium species that were PRO Disc positive could be differentiated from C. difficile by failure to grow on CCFA, different colonial morphology on CCFA, or morphology upon Gram staining.


This article has been cited by other articles:

  • Jackson, S., Calos, M., Myers, A., Self, W. T. (2006). Analysis of Proline Reduction in the Nosocomial Pathogen Clostridium difficile. J. Bacteriol. 188: 8487-8495 [Abstract] [Full Text]  
  • Keel, M. K., Songer, J. G. (2006). The Comparative Pathology of Clostridium difficile-associated Disease. Vet Pathol 43: 225-240 [Abstract] [Full Text]  
  • Arroyo, L. G., Rousseau, J., Willey, B. M., Low, D. E., Staempfli, H., McGeer, A., Weese, J. S. (2005). Use of a Selective Enrichment Broth To Recover Clostridium difficile from Stool Swabs Stored under Different Conditions. J. Clin. Microbiol. 43: 5341-5343 [Abstract] [Full Text]  
  • van Dissel, J. T, de Groot, N., Hensgens, C. M., Numan, S., Kuijper, E. J, Veldkamp, P., van 't Wout, J. (2005). Bovine antibody-enriched whey to aid in the prevention of a relapse of Clostridium difficile-associated diarrhoea: preclinical and preliminary clinical data. J Med Microbiol 54: 197-205 [Abstract] [Full Text]  
  • Fedorko, D. P., Engler, H. D., O'Shaughnessy, E. M., Williams, E. C., Reichelderfer, C. J., Smith, W. I. Jr. (1999). Evaluation of Two Rapid Assays for Detection of Clostridium difficile Toxin A in Stool Specimens. J. Clin. Microbiol. 37: 3044-3047 [Abstract] [Full Text]